|
US3498989A
(en)
|
1969-04-16 |
1970-03-03 |
American Home Prod |
Certain 8-substituted-2-alkyl-3-benzoyl esters of ecgonine and derivatives thereof
|
|
US3870715A
(en)
|
1972-03-09 |
1975-03-11 |
Nikolaus R Hansl |
Substituted amino ethyl meta benzoic acid esters
|
|
US4041174A
(en)
|
1974-08-16 |
1977-08-09 |
Rom-Amer Pharmaceuticals, Ltd. |
Method of treating depression
|
|
US4731379A
(en)
*
|
1983-12-07 |
1988-03-15 |
H.S.C. Corporation |
Flea eradicator
|
|
US5204356A
(en)
|
1985-07-24 |
1993-04-20 |
Glaxo Group Limited |
Treatment of anxiety
|
|
US6150354A
(en)
|
1987-01-15 |
2000-11-21 |
Bonnie Davis |
Compounds for the treatment of Alzheimer's disease
|
|
GB8819494D0
(en)
|
1988-08-16 |
1988-09-21 |
Ucb Sa |
Use of 2-amino-4-morpholino-6-propyl-1 3 5-triazines for preparation of psychotropic medicaments
|
|
CA2058455A1
(en)
*
|
1990-12-21 |
1992-06-22 |
Mark W. Collison |
Synergistic effect of lantibiotics in combination with selected agents against gram positive bacteria
|
|
WO1992014456A1
(en)
*
|
1991-02-22 |
1992-09-03 |
Shapiro Howard K |
Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology
|
|
US6746678B1
(en)
|
1991-02-22 |
2004-06-08 |
Howard K. Shapiro |
Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
|
|
FR2700117B1
(fr)
|
1993-01-07 |
1995-02-03 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
|
|
DE4340273A1
(de)
|
1993-11-26 |
1995-06-01 |
Karla Dr Lehmann |
Arzneimittel zur Prophylaxe des Morbus Alzheimer und zur Verhütung des Fortschreitens dieser Erkrankung
|
|
US5441981A
(en)
*
|
1994-01-27 |
1995-08-15 |
Buckman Laboratories International, Inc. |
Synergistic antimicrobial compositions containing a halogenated acetophenone and an organic acid
|
|
US5453425A
(en)
|
1994-07-11 |
1995-09-26 |
Janssen Pharmaceutica N.V. |
Risperidone oral formulation
|
|
US6146847A
(en)
*
|
1996-11-01 |
2000-11-14 |
Genespan Corporation |
Stabilized transient gene expression
|
|
DE19925425A1
(de)
*
|
1999-06-02 |
2000-12-07 |
Wessollek Heimo |
Mittel zur Entkeimung bzw. keimreduzierenden Gestaltung von Reinigungs-, Sanitär- und Toilettenartikeln sowie kosmetischen Artikeln, Körperpflegeartikeln und dergleichen verkeimungsgefährdeten Gegenständen
|
|
WO2001041707A2
(en)
|
1999-12-08 |
2001-06-14 |
Vanderbilt University |
Modulation of in vivo glutamine and glycine levels in the treatment of autism
|
|
PT1783118E
(pt)
|
2000-08-14 |
2008-08-19 |
Teva Pharma |
Preparação de risperidona
|
|
US20030185754A1
(en)
|
2001-01-16 |
2003-10-02 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
MXPA03006321A
(es)
|
2001-01-16 |
2003-10-06 |
Genset Sa |
Tratamiento de trastornos del sistema nervioso central usando antagonistas de d-aminoacido oxidasa y d-aspartato oxidasa.
|
|
US20100311701A1
(en)
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
|
US20070053976A1
(en)
|
2002-05-17 |
2007-03-08 |
Eisai R & D Management Co., Ltd. |
Novel combination of drugs as antidepressant
|
|
US7053122B2
(en)
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
AU2003274353B2
(en)
|
2002-10-24 |
2007-04-05 |
Merz Pharma Gmbh & Co. Kgaa |
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
|
|
JP5069905B2
(ja)
*
|
2003-01-21 |
2012-11-07 |
アプテュイト （ウエスト ラファイエット）、エルエルシー |
新規な共結晶化
|
|
CA2798615A1
(en)
*
|
2003-01-21 |
2004-08-05 |
Aptuit (West Lafayette), Llc |
Novel cocrystallization of hydrochloric acid salt of an active agent
|
|
WO2004065348A1
(en)
|
2003-01-23 |
2004-08-05 |
Pfizer Products Inc. |
Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof
|
|
EP1628660A4
(en)
|
2003-06-02 |
2010-06-02 |
Samaritan Pharmaceuticals Inc |
METHOD AND COMPOSITIONS FOR MODULATING THE CORTISOL SERUM MIRRORS
|
|
ZA200605384B
(en)
|
2003-12-29 |
2007-10-31 |
Sepracor Inc |
Benzo[D]isoxazol-3-OL DAAO inhibitors
|
|
EP1709053B1
(en)
|
2004-01-27 |
2011-04-06 |
Synthon B.V. |
Stable salts of olanzapine
|
|
ATE454140T1
(de)
|
2004-02-18 |
2010-01-15 |
Sepracor Inc |
Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
|
|
KR20070009671A
(ko)
|
2004-05-06 |
2007-01-18 |
사이덱스 인크 |
세르트랄린 및 술포알킬 에테르 시클로덱스트린을 함유하는맛 마스킹된 제제
|
|
EP1765379A4
(en)
|
2004-06-17 |
2009-05-27 |
Transform Pharmaceuticals Inc |
PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS AND RELEVANT USE METHOD
|
|
WO2006096439A2
(en)
|
2005-03-04 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
|
|
CA2505808A1
(en)
*
|
2005-05-02 |
2006-11-02 |
Julie Danielle Globus |
Niacin used as oral supplementation for the treatment of psychosis and/or schizophrenia in humans
|
|
WO2006129160A2
(en)
|
2005-06-01 |
2006-12-07 |
Aurobindo Pharma Limited |
Stable aqueous oral solution of risperidone
|
|
US20110045065A1
(en)
|
2005-07-11 |
2011-02-24 |
Ashok Vasantray Vyas |
Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof
|
|
US7811604B1
(en)
|
2005-11-14 |
2010-10-12 |
Barr Laboratories, Inc. |
Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
|
|
GB0603181D0
(en)
|
2006-02-17 |
2006-03-29 |
Merck Sharp & Dohme |
Treatment of neurodegenerative and psychiatric diseases
|
|
US20080045547A1
(en)
*
|
2006-07-07 |
2008-02-21 |
Lippa Arnold S |
Salts And Co-Crystals of Pyrazolopyrimidine Compounds, Compositions Thereof And Methods For Their Production And Use
|
|
US20080045512A1
(en)
|
2006-08-09 |
2008-02-21 |
Pfizer Inc. |
Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]-pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane
|
|
WO2008034087A2
(en)
|
2006-09-15 |
2008-03-20 |
Xenoport, Inc. |
Treating schizophrenia with combinations of levodopa and an antipsychotic agent
|
|
US20100204204A1
(en)
*
|
2007-06-06 |
2010-08-12 |
University Of South Florida |
Nutraceutical co-crystal compositions
|
|
US8071143B2
(en)
*
|
2008-04-02 |
2011-12-06 |
Brandeis University |
Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
|
|
US20130338199A1
(en)
|
2008-07-11 |
2013-12-19 |
Uday Saxena |
Novel Niacin Compositions for Reduction of Amyloid Beta Peptide 42 (AB42) Production and for Treatment of Alzheimer's Disease
|
|
GB0813709D0
(en)
*
|
2008-07-26 |
2008-09-03 |
Univ Dundee |
Method and product
|
|
MX2011002312A
(es)
*
|
2008-09-03 |
2011-04-26 |
Vertex Pharma |
Co-cristales y formulaciones farmaceuticas que comprenden los mismos.
|
|
JP2010106001A
(ja)
*
|
2008-10-31 |
2010-05-13 |
Theravalues Corp |
Ｐｐａｒ活性化剤
|
|
CN102292094B
(zh)
|
2009-01-20 |
2013-08-14 |
洛杉矶生物医学研究所在哈伯-加州大学洛杉矶分校医疗中心 |
增强神经药方疗效的山梨酸与苯甲酸及其衍生物
|
|
EP3650439B1
(en)
|
2010-07-23 |
2021-02-24 |
Grünenthal GmbH |
Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
|
|
JP2014508814A
(ja)
|
2011-03-24 |
2014-04-10 |
ユニバーシティ・オブ・サウス・フロリダ |
リチウム組成物
|
|
US9035044B2
(en)
|
2011-05-09 |
2015-05-19 |
Janssen Pharmaceutica Nv |
L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
|
|
PH12012000132A1
(en)
*
|
2011-06-09 |
2014-10-20 |
Servier Lab |
New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
|
|
US9120766B2
(en)
|
2011-10-21 |
2015-09-01 |
Amri Ssci, Llc |
Methods of making cocrystals
|
|
ES2634993T3
(es)
*
|
2012-03-30 |
2017-10-02 |
Nuformix Limited |
Composiciones y cocristales de tranilast
|
|
SI2986618T1
(sl)
*
|
2013-04-19 |
2022-08-31 |
University of South Florida, Division of Patents and Licensing, |
Organske anionske litijeve ionske kokristalne spojine in sestavki
|
|
EP2991999B1
(en)
|
2013-04-29 |
2019-05-08 |
Mapi Pharma Limited |
Dapagliflozin lactose co-crystal
|
|
PL3424920T3
(pl)
*
|
2013-10-17 |
2020-11-16 |
Vertex Pharmaceuticals Incorporated |
Kokryształy (S)-N-metylo-8-(1-((2'-metylo-4’,6'-dideutero-[4,5'-bipirymidyn]-6-ylo)amino)propan-2-ylo)chinolino-4-karboksyamidu i ich deuterowane pochodne jako inhibitory DNA-PK
|
|
ES2788866T3
(es)
*
|
2013-12-13 |
2020-10-23 |
Conaris Res Institute Ag |
Una composición farmacéutica que contiene ácido nicotínico y/o nicotinamida para su uso en influir beneficiosamente en los niveles de lípidos en sangre mediante la modificación de la microbiota intestinal
|
|
JP2016517866A
(ja)
*
|
2014-03-24 |
2016-06-20 |
カオシュン・チャン・グン・メモリアル・ホスピタル |
認知症または軽度認知障害を予防または治療する組成物を製造するための安息香酸塩の使用
|
|
CN103992320A
(zh)
*
|
2014-05-26 |
2014-08-20 |
南京工业大学 |
一种混悬结晶制备药物共晶的方法
|
|
US9896429B2
(en)
*
|
2014-05-27 |
2018-02-20 |
R.J. Reynolds Tobacco Company |
Nicotine salts, co-crystals, and salt co-crystal complexes
|
|
CN113816940A
(zh)
*
|
2014-05-27 |
2021-12-21 |
R.J.雷诺兹烟草公司 |
烟碱盐、共晶体和盐共晶体络合物
|
|
US20170354666A1
(en)
*
|
2014-11-19 |
2017-12-14 |
Rush University Medical Center |
Compositions and methods for treating lysosomal disorders
|
|
RU2582962C1
(ru)
|
2014-12-23 |
2016-04-27 |
Ольга Алексеевна Громова |
Средство для профилактики и лечения нейродегенеративной патологии и сосудистой деменции (варианты)
|
|
CA3027300C
(en)
*
|
2016-06-13 |
2023-08-08 |
Syneurx International (Taiwan) Corp. |
Co-crystals of lithium benzoate and uses thereof
|
|
CA3022020A1
(en)
|
2016-06-14 |
2017-12-21 |
Aemerge Llc |
Hydrocarbon recycling of carbonizer hot gases
|
|
US10064833B2
(en)
*
|
2016-08-04 |
2018-09-04 |
Syneurx International (Taiwan) Corp. |
Compositions containing benzoate compound and tannic acid for treating central nervous system disorders
|
|
US10336679B2
(en)
*
|
2016-10-24 |
2019-07-02 |
Syneurx International (Taiwan) Corp. |
Polymorphic forms of sodium benzoate and uses thereof
|
|
US9877942B1
(en)
*
|
2017-02-13 |
2018-01-30 |
Syneurx International (Taiwan) Corp. |
Co-crystals of substituted glycine and uses thereof
|
|
US20190076472A1
(en)
*
|
2017-09-14 |
2019-03-14 |
CT Development One, LLC |
Hyperammonemia therapy for children suffering from urea cycle disorders
|
|
US10098861B1
(en)
*
|
2017-10-24 |
2018-10-16 |
Syneurx International (Taiwan) Corp. |
Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof
|